Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 1Phase 1/2 1

Status

Unknown 7Recruiting 5Completed 5Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 157INDUSTRY 55NIH 15OTHER_GOV 5NETWORK 3FED 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Dermatologic 3Thoracic 1

Conditions

Melanoma 2Uveal Melanoma 1Efficacy, Team 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Drug Therapy 10pembrolizumab 9Bevacizumab 9Radiotherapy 8Cyclophosphamide 8Carboplatin 8Oxaliplatin 7tislelizumab 6Surgical Procedures, Operative 6Docetaxel 6Cisplatin 6Capecitabine 6Paclitaxel 5Nivolumab 5Fluorouracil 5Control Groups 5fludarabine 4Immune Checkpoint Inhibitors 4Gemcitabine 4Endoscopic Mucosal Resection 4sintilimab 3Trastuzumab 3Pemetrexed 3Neoadjuvant Therapy 3Leucovorin 3Laparoscopy 3Irinotecan 3Injections 3Hematologic Tests 3HMPL-013 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Recruiting × OTHER_GOV × Nivolumab × Clear all
NCT07050043 2025-07-03

LEDANG

Hospital Sultanah Bahiyah

Phase 3 Recruiting
123 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06519266 2024-11-25

SCANDIUM-III

Vastra Gotaland Region

Phase 3 Recruiting
40 enrolled
Dermatologic

Uveal Melanoma

NCT06693440 2024-11-18

The Immune Assessment of PD-1 Antibody Therapy in Tumor

Henan Cancer Hospital

Recruiting
3,000 enrolled

Efficacy, Team

NCT03685890 2024-04-25

NivoILP

Vastra Gotaland Region

Phase 1/2 Recruiting
74 enrolled
Dermatologic

Melanoma

NCT03166397 2023-01-26

Adoptive Cell Therapy Following a Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Melanoma Patients

Sheba Medical Center

Phase 2 Recruiting
30 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡